Article Text

Download PDFPDF
Transmucosal diverticular myotomy for the treatment of oesophageal diverticula associated with spastic motility disorders
  1. Mayenaaz Sidhu1,2,
  2. David J Tate2,3,
  3. Michael J Bourke1,2
  1. 1 Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia
  2. 2 Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
  3. 3 Department of Gastroenterology and Hepatology, Ghent University, Ghent, Belgium
  1. Correspondence to Dr Mayenaaz Sidhu, Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, NSW 2145, Australia; drmsidhu16{at}gmail.com

Abstract

Thoracic oesophageal diverticula are often associated with spastic motility disorders. Despite correction of the underlying motility disorder, in a subgroup of patients, symptoms persist, primarily regurgitation. Surgical diverticulectomy is then proposed; however, as the approach is thoracoscopic or via thoracotomy, it is associated with significant morbidity and cost. Descriptions of endoscopic techniques for the treatment of symptomatic midoesophageal diverticula are few. We propose the novel technique of diverticular myotomy (DM) to treat this disorder. In this case series, we describe two patients who successfully underwent DM with no adverse outcomes and excellent clinical results at 24-month follow-up.

  • endoscopic procedures
  • oesophageal motility
  • diverticular disease
  • achalasia
  • diagnostic and therapeutic endoscopy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors MS: study design, data collection and synthesis and manuscript synthesis; DJT: study design and manuscript synthesis; MJB: original idea and study concept, structure and overall supervision from initial concept to submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Research support from Olympus Australia, Cook Medical and Boston Scientific .

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.